Your browser doesn't support javascript.
loading
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition.
Ghosh, Nilasha; Postow, Michael; Zhu, Chengsong; Jannat-Khah, Deanna; Li, Quan-Zhen; Vitone, Greg; Chan, Karmela K; Bass, Anne R.
Afiliación
  • Ghosh N; Hospital for Special Surgery/Weill Cornell Medical College, Department of Medicine, Division of Rheumatology, New York, NY, USA ghoshn@hss.edu.
  • Postow M; Melanoma & Immunotherapeutics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Zhu C; Department of Immunology, Microarray and Immune Phenotyping Core Facility, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Jannat-Khah D; Hospital for Special Surgery/Weill Cornell Medical College, Department of Medicine, Division of Rheumatology, New York, NY, USA.
  • Li QZ; Department of Immunology, Microarray and Immune Phenotyping Core Facility, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Vitone G; Hospital for Special Surgery, Department of Medicine, Division of Rheumatology, New York, New York, USA.
  • Chan KK; Hospital for Special Surgery/Weill Cornell Medical College, Department of Medicine, Division of Rheumatology, New York, NY, USA.
  • Bass AR; Hospital for Special Surgery/Weill Cornell Medical College, Department of Medicine, Division of Rheumatology, New York, NY, USA.
J Immunother Cancer ; 10(1)2022 01.
Article en En | MEDLINE | ID: mdl-35091456
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos